New evidence; previous conclusions confirmed for Monovalent measles vaccine or combined MMR vaccine versus placebo or no vaccine and Monovalent mumps vaccine or combined MMR vaccine versus placebo or no vaccine.
New evidence; previous conclusions confirmed for Antibiotics (topical plus systemic) in adults, Antibiotics (topical) in adults, Antiseptics (topical) in adults, Antibiotics (topical) in children, and Antiseptics (topical) in children.
New options added for Cinacalcet and Mupirocin (nasal or catheter exit site application). New evidence; conclusions changed for Phosphate binders. New evidence; previous conclusions confirmed for Icodextrin versus dextrose.
New options added for Mepartricin and Quercetin. New evidence; conclusions changed for Alpha-blockers, Oral antimicrobial drugs, and Prostatic massage.
New option added for Corticotropin (adrenocorticotrophic hormone). New evidence; previous conclusions confirmed for Colchicine (oral) for treating acute gout, Corticosteroids, Non-steroidal anti-inflammatory drugs, Advice to lose weight, Advice to reduce alcohol intake, Advice to reduce dietary intake of purines, Colchicine for preventing recurrence, and Sulfinpyrazone.
New options added for Carboprost injection, Prostaglandin E2 compounds, Misoprostol (sublingual), Misoprostol (vaginal), Misoprostol (oral), and Misoprostol (rectal). New evidence; conclusions changed for Controlled cord traction. New evidence; previous conclusions confirmed for Oxytocin.
New search performed and critically appraised; no new evidence selected for inclusion.
February's summary of new and updated conditions for BMJ Clinical Evidence, from the BMJ Publishing Group, the international source of the best available evidence for effective health care
feedcat.net promotes your content, measures audiences and saving load of your server resources!